Calliditas Therapeutics A... (CALT)
NASDAQ: CALT
· Real-Time Price · USD
40.00
-0.04 (-0.10%)
At close: Sep 20, 2024, 10:00 PM
Calliditas Therapeutics AB (publ) Cash Flow Statement
Financials in SEK. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -429.25M | -456.94M | -440.64M | -389.77M | -266.43M | -401.1M | -421.94M | -676.57M | -632.49M | -582.04M | -524.46M | -438.26M | -551.01M | -458.18M |
Depreciation & Amortization | 16.59M | 16.59M | 16.59M | 12.91M | 12.91M | 12.91M | 12.91M | 6.46M | 6.46M | 6.46M | 6.46M | 2.82M | 2.82M | 2.82M |
Stock-Based Compensation | 52.59M | 52.59M | 52.59M | 35.79M | 35.79M | 35.79M | 35.79M | 21.96M | 21.96M | 21.96M | 21.96M | 6.01M | 6.01M | 6.01M |
Other Working Capital | 45.67M | -3.9M | -79.74M | 220.34M | 75.12M | 103.55M | 183.06M | -62.34M | -26.49M | 11.96M | 6.42M | -22.64M | 23.69M | 4.89M |
Other Non-Cash Items | 195.32M | 84.18M | 85.72M | 36.6M | -3.72M | 40.31M | 22.17M | 37.22M | 48.77M | 52.2M | 57.4M | 32.47M | 28.81M | 20.67M |
Deferred Income Tax | n/a | n/a | n/a | -48.7M | -48.7M | -48.7M | -48.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 13.26M | -3.9M | -79.74M | 125.7M | -19.52M | 8.92M | 88.42M | -63.29M | -27.44M | 11.01M | 5.47M | -14.61M | 31.72M | 12.92M |
Operating Cash Flow | -244.93M | -400.92M | -434.65M | -227.47M | -289.67M | -351.87M | -311.35M | -702.64M | -611.16M | -518.83M | -461.59M | -420.41M | -490.48M | -424.58M |
Capital Expenditures | -12.79M | -12.79M | -12.79M | -2.51M | -2.51M | -2.51M | -2.51M | -6.59M | -6.59M | -6.59M | -6.59M | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -39.02M | -39.02M | -36.74M | -36.74M | -170.32M | -170.32M | -172.6M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 117K | -943K | 2K | -10.34M | -3.81M | -2.89M | -2.63M | -9.02M | -8.36M | -26.79M | -24.34M | -191.61M | -191.37M | -172.81M |
Investing Cash Flow | -13.73M | -14.69M | -13.74M | -12.86M | -6.33M | -5.41M | -5.14M | -9.02M | -8.36M | -26.79M | -24.34M | -191.61M | -191.37M | -172.81M |
Debt Repayment | 222.73M | 223.78M | 226.28M | 243.55M | 243.87M | 480.82M | 482.13M | 227.44M | 427.59M | 193.3M | 193.95M | 194.74M | -3.48M | -3.76M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -236K | -236K | -236K | -236K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -26.63M | -26.63M | -26.63M | 30.22M | 30.22M | 32.15M | 93.86M | 24.63M | -10.16M | -12.46M | -82.79M | -121.61M | -79.39M | -115.22M |
Financial Cash Flow | 196.12M | 197.15M | 199.65M | 273.77M | 274.08M | 512.97M | 575.99M | 252.06M | 741.43M | 504.84M | 435.16M | 397.13M | -19.48M | 772.41M |
Net Cash Flow | -68.9M | -203.28M | -275.36M | 50.72M | 19.38M | 188.19M | 293.59M | -427.66M | 137.49M | -41.94M | -40.8M | -233.05M | -750.26M | 138.77M |
Free Cash Flow | -257.72M | -413.71M | -447.44M | -229.98M | -292.18M | -354.38M | -313.87M | -709.22M | -617.74M | -525.42M | -468.18M | -420.41M | -490.48M | -424.58M |